The U.S. Centers for Disease Control and Prevention (CDC) recommend vaccination against tetanus beginning at two months of age. According to the CDC, children should receive a total of five doses of the DTaP vaccine before age six, preteens should receive a Tdap vaccine between the ages of 11 and 12, and adults should receive … Continue reading
The World Health Organization (WHO) recently celebrated World Immunization Week 2022. By recognizing World Immunization Week, the WHO “aims to highlight the collective action needed and to promote the use of vaccines to protect people of all ages against disease.” Here, vaccine injury lawyer Leah V. Durant discusses some of the highlights from the WHO’s … Continue reading
The chickenpox vaccine has proven to be highly effective since its introduction in the 1990s. Today, the U.S. Centers for Disease Control and Prevention (CDC) recommend that children receive the chickenpox vaccine in two doses—one administered at 12 to 15 months of age and another administered between the ages of 4 and 6. Unfortunately, while … Continue reading
The annual flu shot is linked to several types of illnesses and injuries. While these illnesses and injuries are rare overall, due to the sheer number of flu shots administered in the United States, many adults and children experience flu shot-related medical conditions each year. The National Vaccine Injury Compensation Program (VICP) receives hundreds of … Continue reading
The U.S. Centers for Disease Control and Prevention (CDC) recommend that most people get a flu shot each year. For the 2020-2021 flu season, the CDC says that, “[g]etting a flu vaccine is more important than ever.” But, what if you have had an adverse reaction to the flu shot in the past? Should you … Continue reading
The U.S. Food and Drug Administration (FDA) has approved a new meningococcal vaccine for use in the United States. The new vaccine, MenQuadfi, is manufactured by pharmaceutical giant Sanofi Pasteur, Inc. MenQuadfi joins five other meningococcal vaccines that are currently approved for use in the U.S.: Menveo, Menactra, BEXSERO, TRUMENBA and Menomune-A/C/Y/W-135. It is indicated … Continue reading